Record NNP B-NP O
date NN I-NP O
: : O O
2097-06-10 CD O B-DATE
CARDIOLOGY NN B-NP O
WILLOW NNP B-NP B-HOSPITAL
GARDEN NNP I-NP I-HOSPITAL
CARE NNP I-NP I-HOSPITAL
CENTER NNP I-NP I-HOSPITAL
Note VB B-VP O
: : O O
There EX B-NP O
is VBZ B-VP O
an DT B-NP O
addendum NN I-NP O
for IN B-PP O
this DT B-NP O
note NN I-NP O
( -LRB- B-VP O
6/10/2097 CD B-NP B-DATE
) -RRB- O O
Reason NN B-NP O
for IN B-PP O
visit NN B-NP O
: : O O
Mr. NNP B-NP O
Bell NNP I-NP B-PATIENT
is VBZ B-VP O
an DT B-NP O
81 CD I-NP B-AGE
year NN I-NP O
old JJ I-NP O
male NN I-NP O
with IN B-PP O
recent JJ B-NP O
CABG NNP I-NP O
, , O O
now RB B-VP O
admitted VBN I-VP O
via IN B-PP O
EW NNP B-NP O
with IN B-PP O
progressive JJ B-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
and CC I-NP O
hypoxia NN I-NP O
for IN B-PP O
further JJ B-NP O
evaluation NN I-NP O
. . O O
Interval NNP B-NP O
History NN I-NP O
: : O O
He PRP B-NP O
has VBZ B-VP O
multiple JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factors NNS I-NP O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-PP O
CAD NN B-NP O
dating VBG B-VP O
back RB B-ADVP O
to TO B-PP O
April NNP B-NP B-DATE
2097 CD I-NP I-DATE
. . O O
At IN B-PP O
that DT B-NP O
point NN I-NP O
, , O O
he PRP B-NP O
noted VBD B-VP O
increasing VBG I-VP O
chest NN B-NP O
pressure NN I-NP O
and CC I-NP O
dyspnea NN I-NP O
on IN B-PP O
minimal JJ B-NP O
exertion NN I-NP O
. . O O
Following VBG B-VP O
a DT B-NP O
positive JJ I-NP O
stress NN I-NP O
test NN I-NP O
, , O O
he PRP B-NP O
was VBD B-VP O
admitted VBN I-VP O
for IN B-PP O
cardiac JJ B-NP O
catheterization NN I-NP O
. . O O
Coronary NNPS O O
angiography NN B-NP O
revealed VBD B-VP O
severe JJ B-NP O
multi NNS I-NP O
vessel NN I-NP O
CAD. NNP I-NP O
He PRP B-NP O
had VBD B-VP O
an DT B-NP O
IABP NNP I-NP O
placed VBD B-VP O
and CC O O
underwent IN B-PP O
cardiac JJ B-NP O
surgical JJ I-NP O
evaluation NN I-NP O
. . O O
Carotid NNP B-NP O
non-invasive JJ I-NP O
studies NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
moderate JJ I-NP O
right NN I-NP O
carotid NN I-NP O
lesion NN I-NP O
with IN B-PP O
mild JJ B-NP O
left JJ I-NP O
carotid NN I-NP O
disease NN I-NP O
. . O O
He PRP B-NP O
underwent VBD B-VP O
a DT B-NP O
4 CD I-NP O
vessel NN I-NP O
CABG NN I-NP O
by IN B-PP O
Dr. NNP B-NP O
Troyer NNP I-NP B-DOCTOR
. . O O
His PRP$ B-NP O
graft NN I-NP O
anatomy NN I-NP O
includes VBZ B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO B-PP O
the DT B-NP O
LAD NN I-NP O
, , O O
SVG NNP B-NP O
to TO B-PP O
the DT B-NP O
PDA NNP I-NP O
and CC I-NP O
PLV NNP I-NP O
and CC O O
a DT B-NP O
SVG NNP I-NP O
to TO B-PP O
the DT B-NP O
OM NNP I-NP O
branch NN I-NP O
. . O O
He PRP B-NP O
required VBD B-VP O
re-exploration NN B-NP O
for IN B-PP O
bleeding VBG B-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
had VBD B-VP O
atrial JJ B-NP O
fibrillation NN I-NP O
with IN B-PP O
a DT B-NP O
rapid JJ I-NP O
ventricular JJ I-NP O
response NN I-NP O
, , O O
treated VBN B-VP O
with IN B-PP O
Amiodarone NNP B-NP O
. . O O
His PRP$ B-NP O
IABP NNP I-NP O
was VBD B-VP O
removed VBN I-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
post IN B-PP O
operatively NN B-NP O
. . O O
He PRP B-NP O
developed VBD B-VP O
new JJ B-NP O
anterior JJ I-NP O
ST NNS I-NP O
changes NNS I-NP O
, , O O
and CC O O
an DT B-NP O
echocardiogram NN I-NP O
revealed VBD B-VP O
a DT B-NP O
marked JJ I-NP O
decline NN I-NP O
in IN B-PP O
his PRP$ B-NP O
LV NNP I-NP O
function NN I-NP O
from IN B-PP O
66 CD B-NP O
% NN I-NP O
to TO B-PP O
19 CD B-NP O
% NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
taken VBN I-VP O
emergently RB B-ADVP O
to TO B-PP O
the DT B-NP O
cardiac NN I-NP O
catheterization NN I-NP O
lab NN I-NP O
. . O O
Coronary NNPS O O
angiography NN B-NP O
revealed VBD B-VP O
a DT B-NP O
widely RB I-NP O
patent JJ I-NP O
SVG NN I-NP O
to TO B-PP O
OM NNP B-NP O
, , O O
a DT B-NP O
30 CD I-NP O
% NN I-NP O
ostial JJ I-NP O
lesion NN I-NP O
in IN B-PP O
the DT B-NP O
SVG NNP I-NP O
to TO B-PP O
the DT B-NP O
PDA NNP I-NP O
and CC O O
PLV. NNP B-NP O
The DT B-NP O
LIMA NNP I-NP O
was VBD B-VP O
patent NN B-NP O
, , O O
but CC O O
there EX B-NP O
was VBD B-VP O
no DT B-NP O
flow NN I-NP O
into IN B-PP O
the DT B-NP O
distal JJ I-NP O
LAD. NNP I-NP O
He PRP B-NP O
underwent VBD B-VP O
stenting VBG I-VP O
of IN B-PP O
the DT B-NP O
LIMA NNP I-NP O
anastomosis NN I-NP O
into IN B-PP O
the DT B-NP O
LAD NN I-NP O
with IN B-PP O
a DT B-NP O
2.5mm JJ I-NP O
x NN I-NP O
18mm CD I-NP O
, , I-NP O
2.5mm CD I-NP O
x NN I-NP O
12mm CD I-NP O
and CC I-NP O
2.5mm CD I-NP O
x NN I-NP O
12mm IN B-PP O
MiniVision NNP B-NP O
stents NNS I-NP O
. . O O
His PRP$ B-NP O
post NN I-NP O
cardiac NN I-NP O
surgical JJ I-NP O
course NN I-NP O
was VBD B-VP O
further RB I-VP O
complicated VBN I-VP O
by IN B-PP O
a DT B-NP O
Serratia NNP I-NP O
pneumonia NN I-NP O
and CC O O
a DT B-NP O
transient NN I-NP O
worsening VBG B-VP O
renal JJ B-NP O
function NN I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
required VBD B-VP O
sternal JJ B-NP O
rewiring NN I-NP O
for IN B-PP O
sternal JJ B-NP O
instability NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
followed VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Hardin NNP I-NP B-DOCTOR
. . B-VP O
His PRP$ B-NP O
HIT NNP I-NP O
assay NN I-NP O
was VBD B-VP O
borderline VBN I-VP O
negative JJ B-ADJP O
. . O O
He PRP B-NP O
was VBD B-VP O
also RB I-VP O
found VBN I-VP O
to TO I-VP O
have VB I-VP O
a DT B-NP O
factor NN I-NP O
VII NNP I-NP O
deficiency NN I-NP O
, , O O
and CC O O
was VBD B-VP O
treated VBN I-VP O
with IN B-PP O
argatroban NN B-NP O
. . O O
Lower JJR B-NP O
extremity NN I-NP O
non-invasive JJ I-NP O
studies NNS I-NP O
revealed VBD B-VP O
a DT B-NP O
R NN I-NP O
posterior JJ I-NP O
tibial JJ I-NP O
DVT NNP I-NP O
, , O O
and CC O O
he PRP B-NP O
was VBD B-VP O
discharged VBN I-VP O
on IN B-PP O
Fopndaparinux NNP B-NP O
. . O O
A DT B-NP O
follow VBP B-VP O
up RP B-PRT O
echocardiogram NN B-NP O
revealed VBD B-VP O
an DT B-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-PP O
31 CD B-NP O
% NN I-NP O
with IN B-PP O
apical JJ B-NP O
akinesis NN I-NP O
, , O O
with IN B-PP O
only RB B-NP O
mild JJ I-NP O
mitral JJ I-NP O
regurgitation NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
discharged VBN I-VP O
to TO I-VP O
rehab VB I-VP O
on IN B-PP O
post NN B-NP O
operative JJ I-NP O
day NN I-NP O
20 CD I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
discharged VBN I-VP O
from IN B-PP O
rehab NN B-NP O
on IN B-PP O
June NNP B-NP B-DATE
5th JJ I-NP I-DATE
. . B-VP O
On IN B-PP O
June NNP B-NP B-DATE
7th NNP I-NP I-DATE
he PRP B-NP O
was VBD B-VP O
lightheaded JJ B-ADJP O
and CC O O
found VBD B-VP O
to TO I-VP O
be VB I-VP O
hypotensive JJ B-ADJP O
by IN B-PP O
the DT B-NP O
VNA NNP I-NP O
. . O O
His PRP$ B-NP O
systolic JJ I-NP O
pressures NNS I-NP O
were VBD B-VP O
78 CD B-NP O
to TO B-PP O
90 CD B-NP O
mmHg NN I-NP O
, , O O
and CC O O
his PRP$ B-NP O
lisinopril NN I-NP O
was VBD B-VP O
decreased VBN I-VP O
and CC O O
his PRP$ B-NP O
Lasix NNP I-NP O
dose NN I-NP O
was VBD B-VP O
cut VBN I-VP O
in IN B-PP O
half NN B-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
chest NN I-NP O
discomfort NN I-NP O
, , O O
throat NN B-NP O
or CC I-NP O
arm NN I-NP O
discomfort NN I-NP O
or CC I-NP O
palpitations NNS I-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
any DT B-NP O
PND NN I-NP O
, , O O
but CC O O
has VBZ B-VP O
been VBN I-VP O
sleeping VBG I-VP O
in IN B-PP O
a DT B-NP O
hospital NN I-NP O
bed NN I-NP O
with IN B-PP O
the DT B-NP O
head NN I-NP O
elevated VBD B-VP O
45 CD B-NP O
degrees NNS I-NP O
. . O O
The DT B-NP O
family NN I-NP O
updated VBN B-VP O
the DT B-NP O
office NN I-NP O
earlier RBR B-NP O
this DT I-NP O
morning NN I-NP O
- : O O
2 CD B-NP O
pound NN I-NP O
weight NN I-NP O
gain NN I-NP O
and CC I-NP O
shortness NN I-NP O
of IN B-PP O
breath NN B-NP O
. . O O
His PRP$ B-NP O
Lasix NNP I-NP O
was VBD B-VP O
increased VBN I-VP O
to TO B-PP O
40 CD B-NP O
mg NN I-NP O
bid NN I-NP O
. . O O
However RB B-ADVP O
, , O O
when WRB B-ADVP O
seen VBN B-VP O
by IN B-PP O
VNA NNP B-NP O
, , O O
his PRP$ B-NP O
room NN I-NP O
air NN I-NP O
saturation NN I-NP O
was VBD B-VP O
76 CD B-NP O
% NN I-NP O
. . O O
911 CD B-NP O
was VBD B-VP O
called VBN I-VP O
and CC O O
he PRP B-NP O
was VBD B-VP O
brought VBN I-VP O
to TO B-PP O
WGCC NNP B-NP B-HOSPITAL
ED NNP I-NP O
for IN B-PP O
evaluation NN B-NP O
. . O O
Past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
: : O O
CM/CAD NN B-NP O
as IN B-PP O
described VBN B-NP O
, , O O
Hypertension NNP B-NP O
, , O O
Type NNP B-NP O
II NNP I-NP O
DM NNP I-NP O
x NN I-NP O
15 CD B-NP O
yrs NNS I-NP O
- : O O
with IN B-PP O
nephropathy NN B-NP O
, , I-NP O
neuropathy NN I-NP O
and CC I-NP O
retinopathy NN I-NP O
, , O O
Mild NNP B-NP O
renal NNP I-NP O
insufficiency NN I-NP O
, , O O
PVD NNP B-NP O
, , O O
Carotid NNP B-NP O
disease NN I-NP O
, , O O
Factor NNP B-NP O
VII NNP I-NP O
Deficiency NNP I-NP O
, , O O
BPH NNP B-NP O
, , O O
Hearing VBG B-VP O
loss NN B-NP O
, , O O
Vitamin NNP B-NP O
B12 NNP I-NP O
deficiency NN I-NP O
. . O O
PSH NNP B-NP O
: : O O
CABG NNP B-NP O
5/01/97 CD I-NP B-DATE
, , O O
Cataract NNP B-NP O
OD NNP I-NP O
. . O O
Changes NNS B-NP O
to TO B-PP O
Allergies NNP B-NP O
NKA NNP B-NP O
: : O O
No DT B-NP O
Known VBN I-NP O
Allergies NNP I-NP O
- : O O
reaction NN B-NP O
: : O O
[reviewed VBN B-NP O
] SYM O O
Medications NNS B-NP O
( -LRB- B-VP O
Confirmed VBN B-NP O
) -RRB- I-NP O
: : O O
aspirin NN B-NP O
81mg CD I-NP O
po NN I-NP O
daily JJ I-NP O
- : O O
took VBD B-VP O
4 CD B-NP O
this DT I-NP O
AM VBP B-LST O
atenolol NN B-NP O
25mg JJ I-NP O
po NN I-NP O
bid NN I-NP O
fondaparinux NN B-NP O
5mg JJ I-NP O
sc NN I-NP O
daily RB O O
glyburide NN B-NP O
5mg JJ I-NP O
po NN I-NP O
daily RB O O
Lasix NNP B-NP O
40mg CD I-NP O
po NN I-NP O
bid NN I-NP O
magnesium NN B-NP O
oxide NN I-NP O
800 CD I-NP O
mg NN I-NP O
po NN I-NP O
tid NN I-NP O
multivitamins NNS B-NP O
1 CD B-NP O
tab NN I-NP O
po NN I-NP O
daily RB O O
omeprazole NN B-NP O
20mg CD I-NP O
po NN I-NP O
daily RB B-SBAR O
Plavix NNP B-NP O
75mg CD I-NP O
po NN I-NP O
daily RB B-SBAR O
potassium NN B-NP O
chloride NN I-NP O
10mEq IN B-PP O
po NN B-NP O
daily RB B-ADVP O
regular JJ B-NP O
insulin NN I-NP O
sliding VBG I-NP O
scale NN I-NP O
sc NN I-NP O
tid NN I-NP O
simvastatin NN B-NP O
80mg CD I-NP O
po NN I-NP O
qpm NN I-NP O
trazodone DT B-NP O
50mg CD I-NP O
x NN I-NP O
1/2 CD I-NP O
tab NN I-NP O
po NN I-NP O
at IN B-PP O
bedtime NN B-NP O
vitamin NN B-NP O
b12 CD I-NP O
1000 CD I-NP O
mcg JJ I-NP O
po NN I-NP O
daily RB O O
Family NNP B-NP O
history NN I-NP O
: : O O
F NNP B-NP O
deceased JJ I-NP O
with IN B-PP O
cardiomyopathy NN B-NP O
at IN B-PP O
64 CD B-NP B-AGE
; : O O
M NNP B-NP O
deceased VBN B-VP O
with IN B-PP O
CA NNP B-NP O
at IN B-PP O
54 CD B-NP B-AGE
; : O O
1 CD B-NP O
B NNP I-NP O
at IN B-PP O
85 CD B-NP B-AGE
with IN B-PP O
CVA NNP B-NP O
; : O O
1 CD B-NP O
S NNP I-NP O
at IN B-PP O
87 CD B-NP B-AGE
with IN B-PP O
CHF. NNP B-NP O
Social JJ B-NP O
history NN I-NP O
: : O O
Married VBN B-ADJP O
, , O O
6 CD B-NP O
adult NN I-NP O
children NNS I-NP O
, , O O
retired VBD B-VP O
Geochemist NNP B-NP B-PROFESSION
. . O O
Tobacco NNP B-NP O
: : O O
Quit NNP B-NP O
2062 CD I-NP B-DATE
; : O O
ETOH NNP B-NP O
: : O O
None NN B-NP O
; : O O
Caffeine NNP B-NP O
: : O O
1-2 JJ B-NP O
cups/day NN I-NP O
; : O O
Exercise NNP B-NP O
: : O O
Very RB B-VP O
limited VBN I-VP O
since IN B-PP O
discharge NN B-NP O
. . O O
Review NNP B-NP O
of IN B-PP O
systems NNS B-NP O
: : O O
Negative JJ B-NP O
for IN I-NP O
: : O O
Frequent JJ B-NP O
headaches NNS I-NP O
, , O O
recent JJ B-NP O
visual JJ I-NP O
changes NNS I-NP O
, , O O
TIA NNP B-NP O
, , O O
CVA NNP B-NP O
, , O O
syncope NN B-NP O
, , O O
asthma NN B-NP O
, , O O
Liver NNP B-NP O
disease NN I-NP O
, , O O
anemia NN B-NP O
. . O O
Positive JJ B-NP O
for IN I-NP O
: : O O
as IN B-SBAR O
stated VBN B-VP O
, , O O
Laser NNP B-NP O
treatment NN I-NP O
OU RB B-VP O
April NNP B-NP B-DATE
97 CD I-NP I-DATE
, , O O
Hx NNP B-NP O
of IN B-PP O
asbestosis NN B-NP O
, , O O
Remote NNP B-NP O
PUD NNP I-NP O
, , O O
Clotting NNP B-NP O
disorder NN I-NP O
, , O O
PVD NNP B-NP O
- : O O
with IN B-PP O
bilateral JJ B-NP O
claudication NN I-NP O
at IN B-PP O
1 CD B-NP O
block NN I-NP O
. . O O
Physical JJ B-NP O
examination NN I-NP O
: : O O
-Pulse NN B-NP O
: : O O
78 CD O O
-resp. DT B-NP O
rate NN I-NP O
: : O O
20 CD B-NP O
100 CD I-NP O
% NN I-NP O
on IN B-PP O
2L CD B-NP O
-General JJ B-NP O
: : O O
A&amp;O NNP B-NP O
, , O O
well RB B-VP O
developed VBN I-VP O
, , O O
fatigued VBN B-VP O
appearing VBG I-VP O
elderly JJ B-NP O
male NN I-NP O
in IN B-PP O
NAD. NNP B-NP O
-Skin JJ B-NP O
: : O O
Pale NNP B-NP O
, , I-NP O
warm JJ I-NP O
and CC I-NP O
dry JJ I-NP O
. . O O
-HEENT JJ B-NP O
: : O O
NC/AT. NNP B-NP O
WNL NNP I-NP O
. . O O
-Chest NN B-NP O
: : O O
Lung NNP B-NP O
sounds VBZ B-VP O
diminished VBN I-VP O
in IN B-PP O
bases NNS B-NP O
bilaterally RB B-PP O
with IN I-PP O
fine JJ B-NP O
crackles NNS I-NP O
1/4 VBP B-VP O
up RP B-PRT O
. . B-NP O
No DT I-NP O
wheeze NN I-NP O
. . O O
Mid '' O O
sternal JJ B-NP O
incision NN I-NP O
well RB B-VP O
approximated VBN I-VP O
, , O O
without IN B-PP O
drainage NN B-NP O
. . O O
Steri NN B-NP O
strips NNS I-NP O
intact JJ B-ADJP O
. . O O
-Cardiac JJ B-NP O
: : O O
Normal JJ B-NP O
S1 NNP I-NP O
and CC I-NP O
S2 NNP I-NP O
, , O O
with IN B-PP O
a DT B-NP O
1/6 CD I-NP O
systolic JJ I-NP O
murmur NN I-NP O
at IN B-PP O
LSB NNP B-NP O
without IN B-PP O
S3 NNP B-NP O
, , O O
or CC O O
S4 NNP B-NP O
. . O O
No DT B-NP O
rub NN I-NP O
. . O O
-Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
non-tender JJ B-ADJP O
with IN B-PP O
active JJ B-NP O
BS. NNP I-NP O
No DT I-NP O
masses NNS I-NP O
or CC I-NP O
bruits NNS I-NP O
appreciated VBN B-VP O
. . O O
-Extremities NNS B-NP O
: : O O
Femorals NNS B-NP O
1+ VBP B-VP O
bilaterally RB B-ADVP O
without IN B-PP O
bruits NNS B-NP O
. . O O
Distal NN B-NP O
pulses VBZ B-VP O
non-palpable JJ B-ADJP O
. . O O
2+ JJ B-NP O
edema NN I-NP O
. . O O
No DT B-NP O
palpable JJ I-NP O
cords NNS I-NP O
. . O O
-Neuro NNP B-NP O
: : O O
A&amp;O NNP B-NP O
, , O O
grossly RB B-ADVP O
non-focal JJ B-ADJP O
. . O O
-BP JJ B-NP O
: : O O
134/88 CD O O
EKG NNP B-NP O
: : O O
Normal JJ B-ADJP O
sinus IN B-PP O
rhythm NN B-NP O
at IN B-PP O
86 CD B-NP O
bpm NN I-NP O
with IN B-PP O
NSSTTWA NNP B-NP O
V2-V5 NNP I-NP O
, , O O
I PRP B-NP O
and CC O O
aVL. VBG B-SBAR O
Selected NNP B-NP O
recent JJ I-NP O
labs NNS I-NP O
: : O O
Metabolic NNP B-NP O
Date NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
BUN NNP I-NP O
CRE NNP I-NP O
06/10/97 CD B-NP B-DATE
126 CD I-NP O
5.0 CD I-NP O
23 CD I-NP O
1.22 CD O O
Cardiac NNP B-NP O
enzymes NNS I-NP O
Date NNP B-NP O
CK-MB NNP I-NP O
TROP-I NNP I-NP O
NT-BNP . O O
06/10/97 CD B-NP B-DATE
NEGATIVE JJ I-NP O
NEGATIVE JJ I-NP O
12848 CD I-NP O
Liver NN B-NP O
and CC I-NP O
Pancreatic JJ I-NP O
Enzymes NNS I-NP O
Date NNP B-NP O
LIPS NNP I-NP O
06/10/97 CD B-NP B-DATE
50 CD I-NP O
Hematology NNP B-NP O
Date NNP B-NP O
HCT NNP I-NP O
WBC NNP I-NP O
PLT . O O
06/10/97 CD B-NP B-DATE
33.5 CD I-NP O
7.1 CD I-NP O
154 CD O O
Coagulation NN B-NP O
Date NNP B-NP O
PT NNP I-NP O
PT-INR NNP I-NP O
PTT NNP I-NP O
06/10/97 CD B-NP B-DATE
13.8 CD I-NP O
1.2 CD I-NP O
32.2 CD O O
Assessment NNP B-NP O
and CC I-NP O
plan NN I-NP O
: : O O
CM/CAD NN B-NP O
- : O O
with IN B-PP O
recent JJ B-NP O
CABG NNP I-NP O
and CC I-NP O
coronary JJ I-NP O
stenting NN I-NP O
, , O O
now RB B-VP O
admitted VBN I-VP O
via IN B-PP O
the DT B-NP O
EW NNP I-NP O
with IN B-PP O
dyspnea NN B-NP O
and CC I-NP O
hypoxia NN I-NP O
. . O O
Initial JJ B-NP O
cardiac JJ I-NP O
enzyme NN I-NP O
screen NN I-NP O
is VBZ B-VP O
negative JJ B-ADJP O
, , O O
but CC O O
BNP NNP B-NP O
markedly RB B-ADVP O
elevated VBD B-VP O
. . I-VP O
Based VBN I-VP O
on IN B-PP O
exam NN B-NP O
, , O O
suspect VB B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
CHF NNP B-NP O
and CC O O
pleural JJ B-NP O
effusions NNS I-NP O
( -LRB- B-VP O
diuretic JJ B-NP O
medication NN I-NP O
was VBD B-VP O
not RB I-VP O
being VBG I-VP O
taken VBN I-VP O
at IN B-PP O
prescribed JJ B-NP O
dose NN I-NP O
accidentally RB B-ADVP O
) -RRB- B-VP O
. . B-NP O
Will NNP I-NP O
admit VBP B-VP O
for IN B-PP O
diuresis NN B-NP O
, , O O
if IN B-SBAR O
significant JJ B-NP O
effusion NN I-NP O
not RB B-VP O
improving VBG I-VP O
with IN B-PP O
diuretics NNS B-NP O
, , O O
may MD B-VP O
need VB I-VP O
thoracentesis NN B-NP O
. . O O
If IN B-SBAR O
BP NNP B-NP O
allows VBZ B-VP O
, , O O
will MD B-VP O
resume VB I-VP O
low JJ B-NP O
dose NN I-NP O
ACEI IN B-PP O
tomorrow NN B-NP O
. . O O
Check VB B-VP O
echocardiogram NN B-NP O
to TO B-VP O
assess VB I-VP O
EF NNP B-NP O
and CC O O
pericardial JJ B-NP O
effusion NN I-NP O
. . O O
continue VB B-VP O
aspirin VBG I-VP O
and CC O O
Plavix NNP B-NP O
. . O O
Recent JJ B-NP O
DVT NNP I-NP O
- : O O
on IN B-PP O
Fondaparinux NNP B-NP O
- : O O
please VBP B-VP O
continue VB I-VP O
and CC I-VP O
ask VB I-VP O
Dr. NNP B-NP O
Hardin NNP I-NP B-DOCTOR
to TO B-VP O
see VB I-VP O
while IN B-SBAR O
in-patient JJ B-NP O
( -LRB- I-NP O
known VBN B-VP O
to TO B-PP O
him PRP B-NP O
) -RRB- B-NP O
. . O O
DM NNP B-NP O
- : O O
continue VBP B-VP O
current JJ B-NP O
regimen NNS I-NP O
, , O O
follow VB B-VP O
and CC I-VP O
cover VB I-VP O
as RB I-VP O
needed VBN I-VP O
. . O O
Helen NNP B-NP B-DOCTOR
T. NNP I-NP I-DOCTOR
Hattie NNP I-NP I-DOCTOR
Simms NNP I-NP I-DOCTOR
, , O O
NP NNP B-NP O
Signed VBN B-VP O
electronically RB B-ADVP O
by IN B-PP O
Helen NNP B-NP B-DOCTOR
T. NNP I-NP I-DOCTOR
Hattie NNP I-NP I-DOCTOR
Simms NNP I-NP I-DOCTOR
, , O O
NP NNP B-NP O
Addendum NN B-NP O
: : O O
6/10/2097 CD O B-DATE
Patient NNP B-NP O
seen VBN B-VP O
and CC I-VP O
examined VBN I-VP O
. . O O
Case NNP O O
d/w VBZ B-VP O
Hattie NNP B-NP B-DOCTOR
, , O O
NP. NNP B-NP O
Agree NNP I-NP O
with IN B-PP O
assessment NN B-NP O
and CC I-NP O
plan NN I-NP O
. . O O
In IN B-PP O
brief NN B-NP O
, , O O
81 CD B-NP B-AGE
M NNP I-NP O
with IN B-PP O
recent JJ B-NP O
CABG NNP I-NP O
admitted VBD B-VP O
for IN B-PP O
increasing VBG B-VP O
SOB NNP B-NP O
with IN B-PP O
PND NNP B-NP O
and CC I-NP O
orthopnea NNP I-NP O
, , O O
probably RB B-ADVP O
2/2 CD B-NP O
pleural JJ I-NP O
effusion NN I-NP O
. . O O
On IN B-PP O
P/E NNP B-NP O
on IN B-PP O
clinical JJ B-NP O
signs NNS I-NP O
of IN B-PP O
left JJ B-NP O
heart NN I-NP O
failure NN I-NP O
. . O O
Plan NNP B-NP O
: : O O
CXR NNP B-NP O
, , I-NP O
diuresis NN I-NP O
, , I-NP O
+/ JJ I-NP O
- : O O
pleural JJ B-NP O
tap NN I-NP O
. . O O
Ora-Jordan NNP B-NP B-DOCTOR
Yelton NNP I-NP I-DOCTOR
, , O O
MD NNP B-NP O
pager NN I-NP O
# # I-NP O
33436 CD O B-PHONE
Signed VBN B-VP O
electronically RB B-ADVP O
by IN B-PP O
Ora-Jordan NNP B-NP B-DOCTOR
Yelton NNP I-NP I-DOCTOR
, , O O
MD . O O
Document NNP B-NP O
Status NNP I-NP O
: : O O
Final JJ B-ADJP O
with IN B-PP O
Addendum NN B-NP O
